SACRAMENTO, Calif., Feb. 13, 2026 /PRNewswire/ — Lunai Bioworks (NASDAQ: LNAI), an AI-powered biotech and biodefense company, was featured on CNBC’s Business MinuteSACRAMENTO, Calif., Feb. 13, 2026 /PRNewswire/ — Lunai Bioworks (NASDAQ: LNAI), an AI-powered biotech and biodefense company, was featured on CNBC’s Business Minute

Lunai Bioworks (NASDAQ: LNAI) Highlights Drug Discovery and Biodefense AI Platform on CNBC

2026/02/13 21:47
2 min read

SACRAMENTO, Calif., Feb. 13, 2026 /PRNewswire/ — Lunai Bioworks (NASDAQ: LNAI), an AI-powered biotech and biodefense company, was featured on CNBC’s Business Minute. Company CEO David Weinstein shared how the company is using its proprietary AI platform to scale therapeutic discovery and strengthen biodefense preparedness.

“We are deploying AI to accelerate discovery in CNS disease and biodefense,” said David Weinstein, Chief Executive Officer of Lunai Bioworks. “Our platform is built to scale precision biology, reduce development risk, and advance high-impact therapeutic programs more efficiently.”

During the national segment, Weinstein discussed how Lunai integrates multimodal biological datasets, advanced machine learning, and in vivo validation systems to rapidly identify novel targets, optimize drug candidates, and compress development timelines across complex neurological disorders and emerging chemical and biological threat countermeasures.

The CNBC appearance underscores growing investor attention on scalable AI platforms transforming central nervous system therapeutics and national security–focused biodefense innovation. Highlights of the interview aired on Business Minute can be watched via the following link:

https://www.linkedin.com/posts/lunai-bioworks_were-proud-to-share-that-our-client-lunai-activity-7427770187589877760-hp3X

Lunai is actively advancing discussions with leading pharmaceutical companies and government agencies around both their biotech and biodefense capabilities.

About Lunai Bioworks
Lunai Bioworks (NASDAQ: LNAI) is an AI-powered biotech and biodefense company pioneering safe and responsible generative biotechnology. Leveraging advanced machine learning and proprietary phenotypic and neurotoxicity datasets, Lunai is redefining how artificial intelligence can accelerate therapeutic innovation while safeguarding society from emerging threats. For more information, visit https://lunaibioworks.com.

Forward-Looking Statements

This press release contains forward-looking statements, including statements regarding potential clinical impact, therapeutic benefit, development timelines, partnering strategy, and commercial value. These statements are subject to risks and uncertainties that may cause actual results to differ materially. Lunai Bioworks undertakes no obligation to update forward-looking statements, except as required by law.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/lunai-bioworks-nasdaq-lnai-highlights-drug-discovery-and-biodefense-ai-platform-on-cnbc-302687672.html

SOURCE Lunai Bioworks Inc.

Market Opportunity
Luna by Virtuals Logo
Luna by Virtuals Price(LUNAI)
$0.006208
$0.006208$0.006208
+1.80%
USD
Luna by Virtuals (LUNAI) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Exploring Market Buzz: Unique Opportunities in Cryptocurrencies

Exploring Market Buzz: Unique Opportunities in Cryptocurrencies

In the ever-evolving world of cryptocurrencies, recent developments have sparked significant interest. A closer look at pricing forecasts for Cardano (ADA) and rumors surrounding a Solana (SOL) ETF, coupled with the emergence of a promising new entrant, Layer Brett, reveals a complex market dynamic. Cardano's Prospects: A Closer Look Cardano, a stalwart in the blockchain space, continues to hold its ground with its research-driven development strategy. The latest price predictions for ADA suggest potential gains, predicting a double or even quadruple increase in its valuation. Despite these optimistic forecasts, the allure of exponential gains drives traders toward more speculative ventures. The Buzz Around Solana ETF The potential introduction of a Solana ETF has the crypto community abuzz, potentially catapulting SOL prices to new heights. As investors await regulatory decisions, the impact of such an ETF on Solana's value could be substantial, potentially reaching up to $300. However, as with Cardano, the substantial market capitalization of Solana may temper its growth potential. Why Layer Brett is Gaining Traction Amidst established names, a new contender, Layer Brett, has started to capture the market's attention with its early presale stages. Offering a low entry price of just $0.0058 and promising over 700% in staking rewards, Layer Brett presents a tempting proposition for those looking to maximize returns. Comparative Analysis: ADA, SOL, and $LBRETT While both ADA and SOL offer stable investment choices with reliable growth, Layer Brett emerges as a high-risk, high-reward option that could potentially offer significantly higher returns due to its nascent market position and aggressive economic model. Initial presale pricing lets investors get in on the ground floor. Staking rewards currently exceed 690%, a persuasive incentive for early adopters. Backed by Ethereum's Layer 2 for enhanced transaction speed and reduced costs. A community-focused $1 million giveaway to further drive engagement and investor interest. Predicted by some analysts to offer up to 50x returns in coming years. Shifting Sands: Investor Movements As the crypto market landscape shifts, many investors, including those traditionally holding ADA and SOL, are beginning to diversify their portfolios by turning to high-potential opportunities like Layer Brett. The combination of strategic presale pricing and significant staking rewards is creating a momentum of its own. Act Fast: Time-Sensitive Opportunities As September progresses, opportunities to capitalize on these low entry points and high yield offerings from Layer Brett are likely to diminish. With increasing attention and funds being directed towards this new asset, the window to act is closing quickly. Invest in Layer Brett now to secure your position before the next price hike and staking rewards reduction. For more information, visit the Layer Brett website, join their Telegram group, or follow them on X by clicking the following links: Website Telegram X Disclaimer: This is a sponsored press release and is for informational purposes only. It does not reflect the views of Bitzo, nor is it intended to be used as legal, tax, investment, or financial advice.
Share
Coinstats2025/09/18 18:39
Tests 50-day EMA barrier near 183.00

Tests 50-day EMA barrier near 183.00

The post Tests 50-day EMA barrier near 183.00 appeared on BitcoinEthereumNews.com. EUR/JPY remains steady after three days of gains, trading around 182.70 during
Share
BitcoinEthereumNews2026/02/23 17:03
Moonshot MAGAX vs Shiba Inu: The AI-Powered Meme-to-Earn Revolution Challenging a Meme Coin Giant

Moonshot MAGAX vs Shiba Inu: The AI-Powered Meme-to-Earn Revolution Challenging a Meme Coin Giant

Discover how Moonshot MAGAX’s AI-powered meme-to-earn platform outpaces Shiba Inu with innovative tokenomics and growth potential in 2025.
Share
Blockchainreporter2025/09/18 03:15